Clinical Trial Detail

NCT ID NCT04111172
Title Phase 2A Study of Ad5.F35-hGCC-PADRE in Gastrointestinal Malignancies
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Thomas Jefferson University
Indications

pancreatic ductal adenocarcinoma

colorectal adenocarcinoma

esophagus adenocarcinoma

gastric adenocarcinoma

Therapies

Ad5.F35-hGCC-PADRE

Age Groups: adult senior

No variant requirements are available.